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Abstract: The origin of the hepatitis B virus is a subject of wide deliberation among researchers. As a
result, increasing academic interest has focused on the spread of the virus in different animal species.
However, the sources of viral infection for many of these animals are unknown since transmission
may occur from animal to animal, human to human, animal to human, and human to animal. The aim
of this study was to evaluate hepadnavirus circulation in wild and farm animals (including animals
raised under wild or free conditions) from different sites in Brazil and Uruguay using serological
and molecular tools. A total of 487 domestic wild and farm animals were screened for hepatitis
B virus (HBV) serological markers and tested via quantitative and qualitative polymerase chain
reaction (PCR) to detect viral DNA. We report evidence of HBsAg (surface antigen of HBV) and total
anti-HBc (HBV core antigen) markers as well as low-copy hepadnavirus DNA among domestic and
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wild animals. According to our results, which were confirmed by partial genome sequencing, as the
proximity between humans and animals increases, the potential for pathogen dispersal also increases.
A wider knowledge and understanding of reverse zoonoses should be sought for an effective One
Health response.
Keywords: hepadnavirus; animal infectious diseases; disease impact; reverse zoonoses; real-time PCR
1. Introduction
The family Hepadnaviridae consists of hepatotropic enveloped viruses containing partially
double-stranded circular DNA that replicates by reverse transcription [1]. These viruses are
classified into the genera Orthohepadnavirus (mammals) and Avihepadnavirus (birds). Humans and
non-human primates such as chimpanzees (Pan troglodytes), gibbons (Hylobates sp.), gorillas (Gorilla
gorilla), orangutans (Pongo pygmaeus), and woolly monkeys (Lagothrix lagotricha) can be infected by
hepatitis B virus (HBV), which is the prototype species [2–7]. HBV-like viruses are also found in a
variety of other mammals, including woodchucks (WHV) [8], squirrels (GSHV/ASHV) [9,10], bats
(RBHBV/HBHBV/TBHBV) [11], and birds such as ducks (DHBV), geese (GHBV), herons (HHBV), and
storks (STHBV) [2,12–18].
Recent findings have confirmed the circulation of a virus similar to HBV in swine [19,20] and
chickens [21] and demonstrated the presence of endogenous viral elements (EVEs) from hepadnaviruses
in snakes [22,23], turtles, and crocodilians [22]. Furthermore, the creation of a novel genus assigned to
an HBV-like virus circulating among fish has been proposed [24]. Based on these data, hepadnaviruses
might be more ancient than previously thought (>200 million years) [25], and the list of candidate
species that may serve as hepadnavirus hosts or reservoirs is longer than expected.
Human infection by HBV is endemic worldwide [26]. The World Health Organization (WHO)
estimates that 240 million people are chronically infected with HBV [27], and 780,000 people die
annually from the associated complications, such as cirrhosis and liver cancer [28]. Contact with blood
or other body fluids from an infected person leads to the transmission of this pathogen [27]. Although
immunization strategies have been adopted to prevent its spread [26], researchers question whether
the existence of a virus shared by different host species impairs eradication attempts [29].
However, the sources of viral infection for many of these animals are unknown, and hepadnavirus
donors and recipients have not been defined among humans and other animal species [30]. Although
animal-to-human transmission is relatively well described, pathogenic traffic in the opposite direction
is poorly understood. Reverse zoonosis or anthroponosis is a fascinating concept and a main global
issue. Farm animals are transported far and wide and interact with wild species that they would
never have encountered naturally. With a rapid growth in animal production and an increase in the
movement of both animals and humans, a human pathogen could easily circulate and eventually adapt
in different niches/hosts/species [31]. To provide insights about the range of HBV-like hosts, this study
evaluated HBV-like circulation in a variety of wild and farm animals from different regions of Brazil
and Uruguay.
2. Materials and Methods
2.1. Ethics Committee, Study Group, and Sample Collection
This study was approved by the Animal Use Ethics Committees (CEUA) of the institutions
involved under the licenses CBA_02356_013, CEUA/UFRRJ n◦ 375/2013, CEUA/UFMS n◦ 500/2013,
CEUA/UCDB n◦ 1/2013, and CEUA/UFG 086/2014. The capture of wild animals was licensed by
the Instituto Chico Mendes de Conservação da Biodiversidade (SISBIO/ICMBio) under the licenses
SISBIO/ICMBio 35296-2, SISBIO/ICMBio 49647-1, and SISBIO/ICMBio 14576-4) in accordance with
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Brazilian regulations. Appropriate biosecurity techniques and individual protective equipment were
implemented during all procedures involving the collection and handling of biological samples.
The study sample included 487 animals from different sites in Brazil and Uruguay that were
divided into Groups A, B, and C according to the occurrence of human contact and the environment.
Group A corresponded to 200 domestic animals from semi-extensive farms or confined conditions,
and it included 75 domestic pigs (Sus scrofa) from the municipalities of Canelones, Lavalleja, and
Colonia/Uruguay, and 125 equines (Equus ferus caballus) from the municipality of Seropédica/Brazil.
Group B corresponded to 189 domestic animals that were raised in the wild or under free conditions,
and it corresponded to 140 domestic dogs (Canis lupus familiaris) that are used for cattle work and
hunting and have frequent access to farming and wild areas, and they were obtained from the
municipalities of Corumbá/Brazil (Pantanal Biome) and Cumari/Brazil (Cerrado Biome). Finally, Group
C corresponded to 98 free-roaming exotic and wild mammals, including 11 wild boars (Sus scrofa) from
the municipality of Maldonado/Uruguay, 61 wild pigs (Sus scrofa) from the municipalities of Barão de
Melgaço and Corumbá/Brazil (Pantanal Biome), one jaguar (Panthera onca) from the municipality of
Barão de Melgaço/Brazil (Pantanal Biome), and 19 crab-eating foxes (Cerdocyon thous), four maned
wolves (Chrysocyon brachyurus), one crab-eating raccoon (Procyon cancrivorus), and one hoary fox
(Lycalopex vetulus) from the municipality of Cumari/Brazil (Cerrado Biome) (Figure 1).
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Figure 1. Collection sites of animals in the present study. 
Domestic animals were physically restrained. Wild species were actively captured using a 
tranquilizer gun or with Tomahawk box traps that were baited with sardines and boiled chicken, 
followed by chemical immobilization with an intramuscular injection of a combination of zolazepam 
and tiletamine (ZoletilH®, Virbac, São Paulo, Brazil) at dosages of 3–10 mg/kg depending on the target 
species. A total of 5 to 20 mL of venous blood was collected from the cephalic vein using Vacutainer® 
(BD LifeSciences, Franklin Lakes, NJ, USA) 18–21 G needles and directly transferred into vacuum 
tubes containing a gel separator and clot activator (BD Vacutainer® SST II Advance, BD LifeSciences, 
Franklin Lakes, NJ, USA). The tubes were refrigerated (4 °C) until they were processed. After 10–15 
minutes of clot retraction, the samples were centrifuged at 3500 rpm for 5 minutes at room 
temperature (20–22 °C). The sera were separated and stored in aliquots at −20 and −80 °C until further 
analysis. 
Figure 1. Collection sites of animals in the present study.
Domestic animals were physically restrained. Wild species were actively captured using a
tranquilizer gun or with Tomahawk box traps that were baited with sardines and boiled chicken,
followed by chemical immobilization with an intramuscular injection of a combination of zolazepam
and tiletamine (ZoletilH®, Virbac, São Paulo, Brazil) at dosages of 3–10 mg/kg depending on the target
species. A total of 5 to 20 mL of venous blood was collected from the cephalic vein using Vacutainer®
(BD LifeSciences, Franklin Lakes, NJ, USA) 18–21 G needles and directly transferred into vacuum
tubes containing a gel separator and clot activator (BD Vacutainer® SST II Advance, BD LifeSciences,
Franklin Lakes, NJ, USA). The tubes were refrigerated (4 ◦C) until they were processed. After 10–15 min
of clot retraction, the samples were centrifuged at 3500 rpm for 5 min at room temperature (20–22 ◦C).
The sera were separated and stored in aliquots at −20 and −80 ◦C until further analysis.
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2.2. Evaluation of Serological Markers
The serum samples were screened using specific enzyme-linked immunosorbent assay (ELISA)
for HBV serological markers (HBsAg, surface antigen of HBV; and total anti-HBc, an HBV core
antigen) [32]. The immunoassay approaches included antigen capture for the HBsAg test and
antibody competition for the total anti-HBc test. The results were interpreted by comparing the
specimen absorbance values (optical density, OD) at 450 nm to the cut-off (CO) value according to the
manufacturer’s recommendations.
2.3. Reactivity to HBsAg Marker Analysis
Statistical analyses of the HBsAg reactivity of the serum samples based on the OD/CO
ratio among different animal species and/or order were performed in accordance with the
non-parametric Kruskal–Wallis test (95% confidence intervals). A p-value < 0.05 was considered to be
statistically significant.
2.4. Molecular Tests
Viral DNA was extracted from all 487 serum samples using a DNA Purification Kit (QIAamp DNA
Mini Kit, Qiagen®, Hilden, Germany) according to the manufacturer’s recommendations. Extracted
DNA was concentrated to a final volume of 25 µL and analyzed by performing quantitative and
qualitative polymerase chain reaction (PCR). To prevent cross-contamination, HBV-positive controls
were not handled with animal samples.
2.5. Detection and Characterization of Hepadnavirus DNA
To detect hepadnavirus DNA, the samples were evaluated in duplicate by performing real-time
PCR using the TaqMan® method (Life Technologies®, Applied Biosystems, Foster City, CA,
USA). The assay was performed for the pre-S2/S region as previously established [33] using
the following primer pair and fluorescent probe described in the literature: forward primer
(5′-GAATCCTCACAATACCGCAGAGT-3′), reverse primer (5′-GCCAAGACACACGGGTGAT-3′),
and probe (5′-FAM-AAGTCCACCACGAGTCTAG-NFQ/MGB-3′) (Life Technologies®, Applied
Biosystems, Foster City, CA, USA) [32]. Amplification was analyzed using the Applied Biosystems
7500 software. The detection limit of the assay was 5 × 101 copies/µL. For this method, all samples
that crossed the threshold line below 42 cycles and exhibited a characteristic sigmoid curve were
considered positive.
In parallel, qualitative amplification strategies for different regions of the genome were
implemented. Initially, a semi-nested PCR (PS1-S2 and PS1-SR) specific for the pre-S/S gene of
HBV (~1100 bp) was performed as previously described for the first round of amplification [34] and for
the second round [35]. Next, a single-round PCR specific for the core gene of HBV (430 bp) was also
performed as previously described [3]. Amplicons were analyzed by electrophoresis in a 1.5% agarose
gel, stained with ethidium bromide (0.2 µg/mL), and visualized under UV light. Direct sequencing of
amplicons was performed to identify the amplified sequence.
2.6. Phylogenetic Analyses and Recombination Detection
Multiple alignments of sequences obtained from this study and GenBank were performed using
MUSCLE in the SeaView v.4 program [36]. The phylogenetic relationships were estimated using (a) the
maximum likelihood (ML) inference as implemented in PhyML 3 [37] under the GTR+G model of
sequence evolution and (b) a Bayesian Markov chain Monte Carlo (MCMC) method as implemented in
MrBayes v.3.2.5 [38]. The MCMC settings consisted of two simultaneous independent runs with four
chains each that were run for 10 million generations and sampled every 100th generation, yielding
100,000 trees. After eliminating 10% of the samples as burn-in, a consensus tree was built. Statistical
support of clades was measured by a heuristic search with 1000 bootstrap replicates in PhyML [39]
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and the Bayesian posterior probabilities in MrBayes. For the Bayesian analysis, we used a mixed
nucleotide evolution model with a γ-shaped distribution of rates across sites. This model allows for
the integration of selection across all best-fit models. For the ML, the best-fit evolutionary model was
determined using MEGA version 7 using the Bayesian information criterion [40]. To analyze possible
recombination events, the sequence alignment was analyzed with Bootscan, which was implemented
in Simplot and RDP4 [41,42]. The sequences for the Bootscan analysis were grouped according to the
nominal taxa clustering in the phylogenetic tree for each sequence, and the sequence of this study
consisted of the query group.
3. Results
3.1. Serological Tests
Based on our serological tests, 6.78% (33/487) of the samples from the different mammalian orders
and biomes investigated were reactive for HBsAg, indicating the existence of an active infection.
Of these, 18.18% (6/33) of the samples belonged to livestock animals (Group A), including two swine
Sus scrofa and four horses Equus ferus caballus; 33.34% (11/33) corresponded to domestic dogs Canis lupus
familiaris, which were raised wildly or free (Group B); and 48.48% (16/33) corresponded to free-roaming
exotic and wild animals (Group C), including 15 wild pigs Sus scrofa and one jaguar Panthera onca
(Table 1). In addition, the statistical analysis of HBsAg reactivity among different animals studied
grouped by species and/or order revealed a greater reactivity index in Sus scrofa than the other analyzed
species (p < 0.0001) (Figure 2).
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Total anti-HBc was detected in 9.45% (46/487) of the serum samples, indicating previous exposure
of these animals to the virus and viral circulation in both domestic and wild environments. Of
these, 41.30% (19/46) of the samples belonged to livestock animals of Group A, including 15 swine
Sus scrofa and 4 horses Equus ferus caballus; 41.30% (19/46) corresponded to 19 domestic dogs Canis lupus
familiaris of Group B, which were raised under wild or free conditions; and 17.39% (8/46) belonged to
free-roaming exotic and wild animals of Group C, including six wild pigs Sus scrofa, one maned wolf
Chrysocyon brachyurus, and one crab-eating raccoon Procyon cancrivorus. Among the serum samples
classified as reactive for total anti-HBc, 32.61% (15/46) of the samples were also reactive for HBsAg.
3.2. Molecular Tests
Hepadnavirus DNA was detected in 6.57% (32/487) of the investigated samples (Table 1 and
Table S2), with 12.5% (4/32) in Group A, 59.38% (19/32) in Group B, and 28.13% (9/32) in Group C.
Positive samples included one domestic pig Sus scrofa and three horses Equus ferus caballus (Group A);
19 domestic dogs Canis lupus familiaris (Group B); and seven wild pigs Sus scrofa and two crab-eating
foxes Cerdocyon thous (Group C). In these samples, a domestic dog Canis lupus familiaris from the
municipality of Cumari/Brazil was positive for hepadnavirus DNA, and it was sequenced, confirming
a positive result for the pre-S/S gene of HBV (~1100 bp) (GenBank:MF991935). Molecular data
concerning domestic and wildlife species from Groups A, B, and C provide evidence supporting the
hepadnavirus circulation in both environments. A comparison of these environments showed that the
viral DNA detection rate in Sus scrofa pigs was 7-fold higher in wild animals than in livestock. However,
a comparison of different species from the Canidae family belonging to both environments revealed a
similar molecular detection rate between wild species (Cerdocyon thous) and domestic animals (Canis
lupus familiaris). The mobility of domestic dogs between both environments and their contact with other
wild animals may be responsible for these similar rates between representatives of the Canidae family.
3.3. Phylogenetic Tree and Recombination
The phylogenetic inference based on the fragment of the pre-S/S gene of HBV found in
representatives of the Orthohepadnavirus genus showed that the sequence obtained in this study
formed a monophyletic clade with sequences recovered from humans and swine (branch support =
1/96) (Figure 3). The newly described sequence found in the serum from a domestic dog was highly
related to sequences found in the bile of a domestic pig Sus scrofa from Brazil (KC832936) and the serum
of an HBV patient classified as genotype A from Argentina (EU304331), with both samples collected in
2008 (0.89/76) (Figure 3). The nucleotide identity calculated between human and animal hepadnavirus
strains indicated that the newly described hepadnavirus sequence found in domestic dog Canis lupus
familiaris shared 90.4%–98.4% identity with the virus detected in swine Sus scrofa and 84.8%–98.2%
identity with human HBV (Table S1). The Pre-S1 region of the sequence obtained in the present study
compared to the closest phylogenetic sequences showed two substitutions: amino acids 38 (serine→
threonine) and 94 (proline→ threonine). Moreover, the S region presented one substitution in residue
173 (threonine→ proline) (Figure S1). Recombination between nucleotide sequences is a major process
that influences the evolution of most viruses. In many different groups of viruses, gene recombination
is an important evolutionary process that generates much of the genetic diversity. The sequences
obtained in this study were evaluated using a Bootscan analysis based on the fragment of the pre-S/S
gene sequence, although signs of recombination were not observed. These results were reinforced by
the RDP4 analysis.
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Table 1. Prevalence of serological and molecular markers of hepadnavirus in domestic and wild animals from different sites in Brazil and Uruguay. HBc: HBV
core antigen.
Groups Common Name Species Country Municipality
Total
Specimens
n (%)
Reactive Total
Anti-HBc
n (%)
Reactive
HBsAg
n (%)
Detected
Hepadnavirus-DNA
n (%)
A—Domestic raised
in semi-extensive
farms or confined
Domestic pig Sus scrofa Uruguay Canelones/Lavalleja/Colonia 75 (37.50) 15 (20.00) 2 (2.67) 1 (1.34)
Horse Equus feruscaballus Brazil Seropédica 125 (62.50) 4 (3.20) 4 (3.20) 3 (2.40)
Total 200 (100) 19 (9.50) 6 (3.00) 4 (2.00)
B—Domestic raised
wildly or free Domestic dog
Canis lupus
familiaris Brazil Corumbá/Cumari 189 (100) 19 (10.05) 11 (5.82) 19 (10.05)
Total
C—Free-roaming
exotic and wild
mammals
Wild boar Sus scrofa Uruguay Maldonado 11 (11.22) 0 0 0
Wild pig Sus scrofa Brazil Barão deMelgaço/Corumbá 61 (62.24) 6 (9.84) 15 (24.59) 7 (11.48)
Jaguar Panthera onca Brazil Barão de Melgaço 1 (1.02) 0 1 (100) 0
Crab-eating fox Cerdocyon thous Brazil Cumari 19 (19.39) 0 0 2 (10.53)
Maned wolf Chrysocyonbrachyurus Brazil Cumari 4 (4.08) 1 (25.00) 0 0
Crab-eating
raccoon
Procyon
cancrivorus Brazil Cumari 1 (1.02) 1 (100) 0 0
Hoary fox Lycalopex vetulus Brazil Cumari 1 (1.02) 0 0 0
Total 98 (100) 8 (8.16) 16 (16.33) 9 (9.18)
Total 487 (100) 46 (9.45) 33 (6.78) 32 (6.57)
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growth of the companion animal market, climate change, ecosystem disruption, the anthropogenic
development of habitats, and global travel and commerce [31,43]. For example, domestic dogs and cats
are the species most closely associated with humans; thus, they are the most abundant and widespread
mammals in the world. Domestic dogs are present both in urban areas and altered/disturbed
environments (agricultural and rural areas). As the geographical boundaries between humans and
animals decrease, the possibility of pathogen spread increases. However, scientific reports seldom
mention human contributions to the variety of emerging diseases that impact animals [31,44].
After serological screening, the percentages of reactive serum samples to the total anti-HBc marker
in each group revealed previous viral contact between livestock (Group A) and free-roaming animal
populations (Groups B and C), whether domestic or not. Regarding livestock, these data already
constitute the first record of HBV-like circulation in swine herds from Uruguay and in equines from
Brazil. Data in the literature have demonstrated serological and/or molecular evidence of HBV-like
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virus circulation in swine herds from China [19] and Brazil [20], and in chicken flocks in China [21].
Additionally, other hepatitis viruses have been demonstrated in domestic animal populations raised
under confined conditions, and they include hepatitis E virus (HEV) in swine herds [45] and hepatitis
C-like virus in Brazilian equines [46]. Focusing on the analyses for Sus scrofa, the presence of the
total anti-HBc marker in the wild pig population provides evidence of the natural circulation of
an HBV-like virus in free-roaming animals, regardless of their close contact with humans. These
data are relevant since such circulation had already been demonstrated in swine from the domestic
environment [19,20,32].
The viral circulation results in wild environments corroborate those obtained for other wild
animals, such as the maned wolf and crab-eating raccoon, as well as for domestic animals that have
free access to environments in which wild animals circulate, such as domestic dogs. Compared with
domestic animals, dogs from the Pantanal are used for cattle work and employed in the handling and
hunting of wild pigs, whereby they are exposed to the blood and fed the viscera and meat of freshly
deceased animals. In the Cerrado, however, domestic dogs are exposed to a greater diversity of wild
animals because they are used to hunt these animals, although such exposure occurs less frequently
compared with that in the Pantanal. Domestic dogs from the Cerrado biome have a greater capacity
for circulation (especially at night, when they catch wild animals), which increases the likelihood
of contact with blood, saliva, and feces from these animals. Anthropogenic changes to ecosystems
increase the area of shared habitats between humans and animals and thus expose both to new
pathogens. Thus, given their feeding ecology and behaviors, these animals are at risk for infection
through hunting and predation. Our data presented here are consistent with records of mammals and
avian species harboring HBV and HBV-like viruses [11,47]. Another interesting fact is that predation
can increase or decrease the prevalence of infectious diseases, depending on how it affects the frequency
of infected individuals or high-quality hosts in the population [48,49]. Predation intensity on reservoir
populations can alter host–pathogen dynamics [50,51] and even affect pathogen persistence in the
reservoir population [44,52].
In this study, the HBsAg prevalence in livestock was 2.67% for swine and 3.20% for equines.
Compared to the available data in the literature, low infection rates in livestock were also noted for
swine herds from the southern and southeastern regions of Brazil (0.8%) [20], which are areas of low
population endemicity for HBV. However, in highly endemic regions for HBV such as China, the
overall prevalence of HBsAg in swine herds is higher (24.8%) [19]. In this study, the active infection
rate between the analyzed groups was compared, and the results showed that the HBsAg detection
rate was approximately 5-fold higher in free-roaming exotic and wild mammals than in confined or
semi-extensive domestic animals. Distinct proportions between Groups A and C must be further
investigated since they could indicate the existence of a natural source of infection. The simultaneous
reactivity results for both markers (total anti-HBc and HBsAg) revealed active infection in some animals
at the time of collection. However, reactive HBsAg animals were not followed up; thus, it was not
possible to confirm whether the infection was acute or chronic. Furthermore, because the available
sample volumes were limited, it was not possible to assess the anti-HBs levels in eventual cases of
immunity after a probable resolved infection.
Cases of reactivity to HBsAg and non-reactivity to total anti-HBc may be indicative of recent
ongoing infection. In this case, antibody titers against the HBV core antigen (anti-HBc) were not
sufficiently high to yield a positive test [53]. Conversely, non-reactivity to HBsAg and reactivity to
total anti-HBc reactive may indicate a more advanced infection because HBsAg decreases and even
disappears as an acute infection resolves, and it could also indicate immunity due to natural infection
and low-level chronic infection [53,54]. The analysis of HBV-like infection among different animal
species and/or orders indicated greater HBsAg reactivity in Sus scrofa than in the other animal species
(p < 0.0001). Because of the diversity of the investigated species, these results indicate that swine
could serve as a potential experimental model of animal infection, which is important because the
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development of such a model represents a current challenge to advancing research on HBV replication
and new antivirals [20].
This study employed a direct ELISA assay capable of detecting the HBsAg surface antigen as
well as many natural and recombinant mutants with simple or multiple-point mutations. Although
false-negative results are possible for hepadnaviruses other than HBV, we would like to highlight that
our research is aimed at reverse zoonosis events from which human HBV-like viruses could easily
circulate and eventually adapt among different niches/hosts/species. Regarding the total anti-HBc,
we recognize that a perfect methodology in terms of sensitivity and specificity is not available. Every
diagnostic methodology presents its limitations. However, Houareau and collaborators performed an
elegant study from 2006 to 2015 with over 30 million people, and based on this significant number of
samples, they demonstrated that attempting to confirm inconclusive anti-HBc results using up to three
different anti-HBc methodologies was not effective [55].
The sigmoid curves of the qPCR from positive samples crossed the threshold line between 37 and
41 amplification cycles, suggesting a low viral load. This low viral load may explain the difficulty in
performing partial nucleotide sequencing of the genome to confirm HBV-like virus infection, even after
the adoption of DNA concentration strategies. The sensitivity and specificity of molecular diagnosis in
this study were consistent with data reported previously in the literature [32]. Although qualitative
PCR for ORF S and ORF C did not confirm active infection in all seroreactive animals, numerous
empty spherical and filamentous particles released during the HBV replicative cycle may have been
responsible for the serological diagnosis of reactive HBsAg. Furthermore, the HBsAg levels decrease
more slowly than HBV-DNA levels because HBsAg has a longer half-life in serum [53].
The genetic distance data indicated that HBV-like canine sequences are closely related to human
HBV sequences, which might suggest the likely direction of infection among different hosts. To ensure
the quality of our results and exclude the possibility of contamination with viral sequences from other
sources, all good laboratory practices were adopted. In addition to the use of filter tip pipettes, we
used a Class II Type B2 Biological Safety Cabinet, disposable masks, coats, gloves, and other basic
biosafety items. It should be reiterated that we did not manipulate the human HBV positive controls.
Our results were not associated with possible contamination, and the sequence obtained in this study
was genetically different from the others found in GenBank. Amino acid substitutions were found in
the viral sequence obtained here, with two found in the pre-S1 region and one in the S region. The
preS domain (preS1 + preS2 + S) of HBV codes for the proteins in the HBsAg compound and plays a
key role in viral infection because it attaches to hepatocytes via interactions with their receptors and
contains several immunogenic epitopes [56]. Authors have suggested that the preS domain determines
the range of the host and specificity of hepadnaviruses. This host specificity for hepadnaviruses is
likely determined by an initial infection step involving the adaptation of the N-terminal preS domain of
the L protein to an unknown cellular factor. Furthermore, additional viral and host determinants may
occur and should be identified [57–59]. Taken together, we conclude that further studies are required
to clarify whether the amino acid substitutions found among hepadnaviruses imply different affinities
for human and animal hepatocytes. These possibilities should be analyzed in new samplings, and
could reveal whether viral circulation reflects an eventual adaption to different niches/hosts/species.
Based on these data and the flexibility of circulation between different environments, domestic dogs
may serve as a domestic–wild link that contributes to the introduction or permanence of the virus
in the wild environment due to their ecology and behavior, which could justify the higher rates of
active infection and percentages of molecular detection compared to domestic environments in this
study [43,60].
5. Conclusions
Hepadnaviruses are zoonotic agents that circulate in different host species—both domestic and
wild. Epidemiological studies focused on zoonotic agents in free-roaming animals must be performed.
The presence of these infectious agents in new free-roaming species indicates the complexity of
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the transmission cycle due to the involvement of multiple host species; thus, molecular studies of
the Hepadnaviridae family are warranted. However, scientific research seldom mentions the human
contributions to the variety of diseases that impact animals. Future investigations of reverse zoonoses
should consider both transmission routes and disease prevalence. Prospective research should also
include a wider variety of etiological agents and animal species associated with HBV-like viruses. The
serological and molecular results of this study suggest that the scientific literature must detail the
presence and transmission of human diseases in animals (animal to animal, human to human, animal
to human, and human to animal) to obtain greater knowledge and understanding of reverse zoonoses
for an effective One Health response.
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